Advertisement
Screener

OptimizeRx Corporation (OPRX) Spending and interest coverage

OptimizeRx Corporation (OPRX) Spending and interest coverage

  • R&D / revenue · 12 months: Value 0.34%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 8.06%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months0.34%Research and development expense / revenue. Period ending 2026-06-30.

$332.00K ÷ $98.65M × 100 ≈ 0.34%

Stock-based compensation / revenue · 12 months8.06%Share-based compensation / revenue. Period ending 2026-06-30.

$7.95M ÷ $98.65M × 100 ≈ 8.06%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending332.00K USDResearch and Development Expense
Revenue98.65M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation7.95M USDShare-based Payment Arrangement, Noncash Expense
Operating income10.90M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$332.00K$98.65M$7.95M$10.90M(m)0.34%8.06%(m)(m)
2026-03-31$150.00K$107.34M$7.23M$14.19M(m)0.14%6.74%(m)(m)
2025-12-31$0.00$109.43M$6.96M$11.69M(m)0.00%6.36%(m)(m)
2025-09-30(m)$109.51M$7.94M$6.76M(m)(m)7.25%(m)(m)
2025-06-30(m)$104.75M$8.59M$-3.85M(m)(m)8.20%(m)(m)
2025-03-31(m)$94.36M$10.00M$-10.79M(m)(m)10.60%(m)(m)
2024-12-31(m)$92.13M$11.47M$-13.71M(m)(m)12.45%(m)(m)
2024-09-30(m)$88.18M$11.16M$-28.24M(m)(m)12.65%(m)(m)
2024-06-30(m)$83.20M$11.76M$-23.30M(m)(m)14.13%(m)(m)
2024-03-31(m)$78.21M$12.36M$-24.37M(m)(m)15.80%(m)(m)
2023-12-31(m)$71.52M$13.72M$-26.40M$1.45M(m)19.18%-18.16×Reported
2023-09-30(m)$1.38M$15.36M$-16.36M(m)(m)1111.47%(m)(m)
2023-06-30(m)$135.88K$16.43M$-16.57M(m)(m)12091.48%(m)(m)
2023-03-31(m)$296.38K$16.95M$-15.59M(m)(m)5719.76%(m)(m)
2022-12-31(m)$1.02M$15.75M$-12.29M(m)(m)1536.18%(m)(m)
2022-09-30(m)$63.11M(m)$-10.81M(m)(m)(m)(m)(m)
2022-06-30(m)$64.15M(m)$-7.01M(m)(m)(m)(m)(m)
2022-03-31(m)$63.79M(m)$-2.76M(m)(m)(m)(m)(m)
2021-12-31(m)$61.29M(m)$361.10K(m)(m)(m)(m)(m)
2021-09-30(m)$57.41M$3.47M$1.10M(m)(m)6.04%(m)(m)
2021-06-30(m)$51.80M$3.09M$881.58K(m)(m)5.97%(m)(m)
2021-03-31(m)$46.96M$3.00M$-514.38K(m)(m)6.39%(m)(m)
2020-12-31$0.00$43.31M$3.17M$-2.14M(m)0.00%7.33%(m)(m)
2020-09-30(m)$34.27M$2.92M$-5.81M(m)(m)8.52%(m)(m)
2020-06-30(m)$28.75M$2.76M$-7.62M(m)(m)9.59%(m)(m)
2020-03-31(m)$26.97M$2.48M$-6.08M(m)(m)9.21%(m)(m)
2019-12-31$1.60M$24.60M$2.26M$-3.69M(m)6.52%9.19%(m)(m)
2019-09-30(m)$23.80M$2.03M$-1.50M(m)(m)8.53%(m)(m)
2019-06-30(m)$24.21M$1.91M$709.94K(m)(m)7.88%(m)(m)
2019-03-31(m)$22.30M$1.93M$503.49K(m)(m)8.64%(m)(m)
2018-12-31(m)$21.21M$1.86M$180.13K(m)(m)8.79%(m)(m)
2018-09-30(m)(m)(m)$66.27K(m)(m)(m)(m)(m)
2018-06-30(m)(m)(m)$-786.56K(m)(m)(m)(m)(m)
2018-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-12-31(m)(m)$87.38K$-2.13M(m)(m)(m)(m)(m)
2017-09-30(m)$10.41M$237.04K$-2.26M(m)(m)2.28%(m)(m)
2017-06-30(m)$9.10M$276.66K$-1.88M(m)(m)3.04%(m)(m)
2017-03-31(m)$8.14M$209.78K$-2.11M(m)(m)2.58%(m)(m)
2016-12-31(m)$7.75M$175.18K$-1.58M(m)(m)2.26%(m)(m)
2016-09-30(m)$7.48M$426.00K$-1.63M(m)(m)5.70%(m)(m)
2016-06-30(m)$7.70M$373.41K$-1.29M(m)(m)4.85%(m)(m)
2016-03-31(m)$7.49M$353.37K$-847.74K(m)(m)4.72%(m)(m)
2015-12-31(m)$7.22M$327.75K$-597.41K$0.00(m)4.54%(m)Reported
2015-09-30(m)$7.17M$788.31K$49.12K(m)(m)11.00%(m)(m)
2015-06-30(m)$6.98M$838.87K$-333.29K(m)(m)12.02%(m)(m)
2015-03-31(m)$6.70M$917.04K$-375.62K(m)(m)13.69%(m)(m)
2014-12-31(m)$6.50M$899.44K$-1.03M$0.00(m)13.83%(m)Reported
2014-09-30(m)$6.20M$664.40K$-495.45K(m)(m)10.71%(m)(m)
2014-06-30(m)$5.96M$543.12K$-242.44K(m)(m)9.12%(m)(m)
2014-03-31(m)$5.61M$832.99K$-213.33K(m)(m)14.86%(m)(m)
2013-12-31(m)$4.96M$411.41K$215.60K(m)(m)8.30%(m)(m)
2013-09-30(m)$3.90M$368.51K$378.87K(m)(m)9.46%(m)(m)
2013-06-30(m)$2.98M$77.23K$262.02K(m)(m)2.59%(m)(m)
2013-03-31(m)$2.39M$168.06K$-168.31K(m)(m)7.04%(m)(m)
2012-12-31(m)$2.05M$285.61K$-364.35K$100.00(m)13.94%-3643.45×Reported
2012-09-30(m)$1.62M(m)$99.11K$-100.00(m)(m)(m)Reported
2012-06-30(m)$1.36M(m)$-1.17M$-958.58K(m)(m)(m)Reported
2012-03-31(m)$1.05M(m)$-1.51M$-818.64K(m)(m)(m)Reported
2011-12-31(m)$1.11M(m)$-1.45M$-958.64K(m)(m)(m)Reported
2011-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-12-31(m)$71.06K(m)$-1.85M$-106.55K(m)(m)(m)Reported
2010-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14